Contrast-Enhanced Digital Mammography (CEDM) vs Contrast-Enhanced Breast MRI (CE-MRI) in Patients With Known Breast Cancer

The primary objective is to determine how accurately one can estimate the size of the index tumor on preoperative imaging in patients with known breast cancer, using pathology as a reference standard. The primary endpoint, which will be measured on CEDM,and CE-MRI, is the maximum diameter (mm) of the index tumor.

Stanford is now accepting new patients for this trial. Please contact Sumita Sood at 650-723-0186 for more information.

Investigator(s):

Phase: Phase 2

Eligibility

Ages Eligible For Study:

18 Years - 70 Years

External Links

Explore related trials

Contact information

Primary Contact:

Sumita Sood 650-723-0186

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: